Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-demecolcine | increases expression | ISO | ZBTB1 (Homo sapiens) | 6480464 | Demecolcine results in increased expression of ZBTB1 mRNA | CTD | PMID:23649840 | 1,2-dichloroethane | decreases expression | ISO | Zbtb1 (Mus musculus) | 6480464 | ethylene dichloride results in decreased expression of ZBTB1 mRNA | CTD | PMID:28960355 | 1,2-dimethylhydrazine | decreases expression | ISO | Zbtb1 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of ZBTB1 mRNA | CTD | PMID:22206623 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | ZBTB1 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin affects the expression of ZBTB1 mRNA | CTD | PMID:22298810 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of ZBTB1 mRNA | CTD | PMID:32109520 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Zbtb1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of ZBTB1 mRNA | CTD | PMID:21570461 and PMID:24680724 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | ZBTB1 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of ZBTB1 mRNA | CTD | PMID:20106945 and PMID:21632981 | 2-deoxy-D-glucose | increases expression | ISO | ZBTB1 (Homo sapiens) | 6480464 | Deoxyglucose results in increased expression of ZBTB1 mRNA | CTD | PMID:33770205 | 3,4-dichloroaniline | increases expression | ISO | ZBTB1 (Homo sapiens) | 6480464 | 3 and 4-dichloroaniline results in increased expression of ZBTB1 mRNA | CTD | PMID:24172598 | 3,4-methylenedioxymethamphetamine | decreases expression | ISO | Zbtb1 (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of ZBTB1 mRNA | CTD | PMID:26251327 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | ZBTB1 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ZBTB1 mRNA | CTD | PMID:28628672 | 4,4'-sulfonyldiphenol | multiple interactions | ISO | ZBTB1 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ZBTB1 mRNA | CTD | PMID:28628672 | aflatoxin B1 | decreases methylation | ISO | ZBTB1 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of ZBTB1 gene | CTD | PMID:27153756 | amphetamine | decreases expression | EXP | | 6480464 | Amphetamine results in decreased expression of ZBTB1 mRNA | CTD | PMID:30779732 | aristolochic acid A | decreases expression | ISO | ZBTB1 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of ZBTB1 mRNA | CTD | PMID:33212167 | arsenous acid | increases expression | ISO | ZBTB1 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of ZBTB1 mRNA | CTD | PMID:18231732 | belinostat | decreases expression | ISO | ZBTB1 (Homo sapiens) | 6480464 | belinostat results in decreased expression of ZBTB1 mRNA | CTD | PMID:27188386 | benzo[a]pyrene | increases expression | ISO | ZBTB1 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of ZBTB1 mRNA | CTD | PMID:20064835 and PMID:20106945 | benzo[a]pyrene | affects methylation | ISO | ZBTB1 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of ZBTB1 5' UTR | CTD | PMID:27901495 | benzo[a]pyrene diol epoxide I | decreases expression | ISO | ZBTB1 (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:19150397 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of ZBTB1 mRNA | CTD | PMID:25181051 | bisphenol A | decreases expression | ISO | Zbtb1 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of ZBTB1 mRNA | CTD | PMID:33221593 | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of ZBTB1 gene | CTD | PMID:28505145 | butanal | decreases expression | ISO | ZBTB1 (Homo sapiens) | 6480464 | butyraldehyde results in decreased expression of ZBTB1 mRNA | CTD | PMID:26079696 | cadmium dichloride | decreases expression | EXP | | 6480464 | Cadmium Chloride results in decreased expression of ZBTB1 mRNA | CTD | PMID:33453195 | cadmium dichloride | increases expression | ISO | ZBTB1 (Homo sapiens) | 6480464 | Cadmium Chloride results in increased expression of ZBTB1 mRNA | CTD | PMID:33770205 | caffeine | decreases phosphorylation | ISO | ZBTB1 (Homo sapiens) | 6480464 | Caffeine results in decreased phosphorylation of ZBTB1 protein | CTD | PMID:35688186 | clorgyline | increases expression | ISO | ZBTB1 (Homo sapiens) | 6480464 | Clorgyline results in increased expression of ZBTB1 mRNA | CTD | PMID:19691856 | cobalt dichloride | increases expression | ISO | ZBTB1 (Homo sapiens) | 6480464 | cobaltous chloride results in increased expression of ZBTB1 mRNA | CTD | PMID:19376846 | copper atom | multiple interactions | ISO | ZBTB1 (Homo sapiens) | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of ZBTB1 mRNA | CTD | PMID:20971185 | copper(0) | multiple interactions | ISO | ZBTB1 (Homo sapiens) | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of ZBTB1 mRNA | CTD | PMID:20971185 | coumarin | decreases phosphorylation | ISO | ZBTB1 (Homo sapiens) | 6480464 | coumarin results in decreased phosphorylation of ZBTB1 protein | CTD | PMID:35688186 | coumestrol | decreases expression | ISO | ZBTB1 (Homo sapiens) | 6480464 | Coumestrol results in decreased expression of ZBTB1 mRNA | CTD | PMID:19167446 | dexamethasone | multiple interactions | ISO | ZBTB1 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ZBTB1 mRNA | CTD | PMID:28628672 | diarsenic trioxide | increases expression | ISO | ZBTB1 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of ZBTB1 mRNA | CTD | PMID:18231732 | dicrotophos | decreases expression | ISO | ZBTB1 (Homo sapiens) | 6480464 | dicrotophos results in decreased expression of ZBTB1 mRNA | CTD | PMID:28302478 | diuron | increases expression | ISO | ZBTB1 (Homo sapiens) | 6480464 | Diuron metabolite results in increased expression of ZBTB1 mRNA | CTD | PMID:24172598 | dorsomorphin | multiple interactions | ISO | ZBTB1 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ZBTB1 mRNA | CTD | PMID:27188386 | epoxiconazole | increases expression | ISO | Zbtb1 (Mus musculus) | 6480464 | epoxiconazole results in increased expression of ZBTB1 mRNA | CTD | PMID:35436446 | fipronil | decreases expression | EXP | | 6480464 | fipronil results in decreased expression of ZBTB1 mRNA | CTD | PMID:34044035 | formaldehyde | decreases expression | ISO | ZBTB1 (Homo sapiens) | 6480464 | Formaldehyde results in decreased expression of ZBTB1 mRNA | CTD | PMID:20655997 | formaldehyde | increases expression | ISO | ZBTB1 (Homo sapiens) | 6480464 | Formaldehyde results in increased expression of ZBTB1 mRNA | CTD | PMID:23649840 | FR900359 | increases phosphorylation | ISO | ZBTB1 (Homo sapiens) | 6480464 | FR900359 results in increased phosphorylation of ZBTB1 protein | CTD | PMID:37730182 | geraniol | increases expression | ISO | ZBTB1 (Homo sapiens) | 6480464 | geraniol results in increased expression of ZBTB1 mRNA | CTD | PMID:27683099 | indometacin | multiple interactions | ISO | ZBTB1 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ZBTB1 mRNA | CTD | PMID:28628672 | leflunomide | increases expression | ISO | ZBTB1 (Homo sapiens) | 6480464 | leflunomide results in increased expression of ZBTB1 mRNA | CTD | PMID:28988120 | mercury atom | increases expression | ISO | ZBTB1 (Homo sapiens) | 6480464 | Mercury results in increased expression of ZBTB1 mRNA | CTD | PMID:16823088 | mercury(0) | increases expression | ISO | ZBTB1 (Homo sapiens) | 6480464 | Mercury results in increased expression of ZBTB1 mRNA | CTD | PMID:16823088 | methylmercury chloride | increases expression | ISO | ZBTB1 (Homo sapiens) | 6480464 | methylmercuric chloride results in increased expression of ZBTB1 mRNA | CTD | PMID:23179753 and PMID:27188386 | methylparaben | decreases expression | ISO | ZBTB1 (Homo sapiens) | 6480464 | methylparaben results in decreased expression of ZBTB1 mRNA | CTD | PMID:31745603 | N-methyl-4-phenylpyridinium | decreases expression | EXP | | 6480464 | 1-Methyl-4-phenylpyridinium results in decreased expression of ZBTB1 mRNA | CTD | PMID:28801915 | panobinostat | decreases expression | ISO | ZBTB1 (Homo sapiens) | 6480464 | Panobinostat results in decreased expression of ZBTB1 mRNA | CTD | PMID:33770205 | phenylmercury acetate | increases expression | ISO | ZBTB1 (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in increased expression of ZBTB1 mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | ISO | ZBTB1 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ZBTB1 mRNA | CTD | PMID:27188386 | pirinixic acid | decreases expression | ISO | Zbtb1 (Mus musculus) | 6480464 | pirinixic acid results in decreased expression of ZBTB1 mRNA | CTD | PMID:20813756 | quercetin | increases expression | ISO | ZBTB1 (Homo sapiens) | 6480464 | Quercetin results in increased expression of ZBTB1 mRNA | CTD | PMID:21632981 | SB 431542 | multiple interactions | ISO | ZBTB1 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ZBTB1 mRNA | CTD | PMID:27188386 | silicon dioxide | decreases expression | ISO | Zbtb1 (Mus musculus) | 6480464 | Silicon Dioxide results in decreased expression of ZBTB1 mRNA | CTD | PMID:19073995 | silver atom | decreases expression | ISO | Zbtb1 (Mus musculus) | 6480464 | Silver results in decreased expression of ZBTB1 mRNA | CTD | PMID:27131904 | silver(0) | decreases expression | ISO | Zbtb1 (Mus musculus) | 6480464 | Silver results in decreased expression of ZBTB1 mRNA | CTD | PMID:27131904 | sodium dichromate | increases expression | ISO | ZBTB1 (Homo sapiens) | 6480464 | sodium bichromate results in increased expression of ZBTB1 mRNA | CTD | PMID:17685462 | titanium dioxide | decreases expression | ISO | Zbtb1 (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of ZBTB1 mRNA | CTD | PMID:29264374 | trichostatin A | decreases expression | ISO | ZBTB1 (Homo sapiens) | 6480464 | trichostatin A results in decreased expression of ZBTB1 mRNA | CTD | PMID:24935251 | trichostatin A | affects expression | ISO | ZBTB1 (Homo sapiens) | 6480464 | trichostatin A affects the expression of ZBTB1 mRNA | CTD | PMID:28542535 | valproic acid | increases methylation | ISO | ZBTB1 (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of ZBTB1 gene | CTD | PMID:29154799 | valproic acid | decreases expression | ISO | ZBTB1 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of ZBTB1 mRNA | CTD | PMID:22083351 more ... | valproic acid | affects expression | ISO | ZBTB1 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of ZBTB1 mRNA | CTD | PMID:25979313 | vanadyl sulfate | decreases expression | ISO | ZBTB1 (Homo sapiens) | 6480464 | vanadyl sulfate results in decreased expression of ZBTB1 mRNA | CTD | PMID:16330358 | vorinostat | decreases expression | ISO | ZBTB1 (Homo sapiens) | 6480464 | Vorinostat results in decreased expression of ZBTB1 mRNA | CTD | PMID:22083351 more ... | zinc atom | multiple interactions | ISO | ZBTB1 (Homo sapiens) | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of ZBTB1 mRNA | CTD | PMID:18593933 | zinc(0) | multiple interactions | ISO | ZBTB1 (Homo sapiens) | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of ZBTB1 mRNA | CTD | PMID:18593933 | |